Beyond Air, Inc. (XAIR)
USD 0.25
(-2.35%)
USD 0.25
(-2.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 61.7 Million USD | 19.8% |
| 2023 | 51.5 Million USD | 70.49% |
| 2022 | 30.21 Million USD | 30.86% |
| 2021 | 23.08 Million USD | 18.2% |
| 2020 | 19.53 Million USD | 81.14% |
| 2019 | 10.78 Million USD | -2.57% |
| 2018 | 11.06 Million USD | 374.37% |
| 2017 | 2.33 Million USD | 7866.26% |
| 2016 | 29.28 Thousand USD | -99.31% |
| 2015 | 4.24 Million USD | 170.62% |
| 2014 | 1.56 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 15.63 Million USD | 14.25% |
| 2024 Q4 | 12.12 Million USD | -25.54% |
| 2024 Q2 | 17.34 Million USD | 10.94% |
| 2024 Q3 | 16.27 Million USD | -6.12% |
| 2024 FY | 61.7 Million USD | 19.8% |
| 2023 Q2 | 12.44 Million USD | 8.76% |
| 2023 Q3 | 13.94 Million USD | 12.05% |
| 2023 Q4 | 13.68 Million USD | -1.87% |
| 2023 FY | 51.5 Million USD | 70.49% |
| 2023 Q1 | 11.44 Million USD | 15.19% |
| 2022 Q4 | 9.93 Million USD | 32.66% |
| 2022 Q2 | 6.2 Million USD | -5.9% |
| 2022 FY | 30.21 Million USD | 30.86% |
| 2022 Q1 | 6.59 Million USD | 27.25% |
| 2022 Q3 | 7.48 Million USD | 20.7% |
| 2021 Q4 | 5.17 Million USD | -10.16% |
| 2021 Q2 | 5.31 Million USD | -22.12% |
| 2021 Q3 | 5.76 Million USD | 8.45% |
| 2021 FY | 23.08 Million USD | 18.2% |
| 2021 Q1 | 6.82 Million USD | 34.93% |
| 2020 Q4 | 5.05 Million USD | 0.13% |
| 2020 FY | 19.53 Million USD | 81.14% |
| 2020 Q3 | 5.05 Million USD | 2.8% |
| 2020 Q2 | 4.91 Million USD | 9.07% |
| 2020 Q1 | 4.5 Million USD | 7.02% |
| 2019 Q1 | 1.75 Million USD | -28.03% |
| 2019 FY | 10.78 Million USD | -2.57% |
| 2019 Q4 | 4.21 Million USD | 75.13% |
| 2019 Q3 | 2.4 Million USD | -0.36% |
| 2019 Q2 | 2.41 Million USD | 37.41% |
| 2018 Q4 | 2.44 Million USD | 2.39% |
| 2018 FY | 11.06 Million USD | 374.37% |
| 2018 Q1 | 3.06 Million USD | -13.85% |
| 2018 Q2 | 2.05 Million USD | -32.93% |
| 2018 Q3 | 2.38 Million USD | 15.85% |
| 2017 Q4 | 3.56 Million USD | 454.52% |
| 2017 FY | 2.33 Million USD | 7866.26% |
| 2017 Q2 | 8684.00 USD | -50.97% |
| 2017 Q1 | 17.71 Thousand USD | 597.24% |
| 2017 Q3 | 642 Thousand USD | 7292.91% |
| 2016 Q2 | 6140.00 USD | -99.24% |
| 2016 FY | 29.28 Thousand USD | -99.31% |
| 2016 Q4 | 2540.00 USD | -12.32% |
| 2016 Q3 | 2897.00 USD | -52.82% |
| 2016 Q1 | 807.5 Thousand USD | 0.0% |
| 2015 Q4 | 807.5 Thousand USD | 45.36% |
| 2015 Q2 | 555.5 Thousand USD | -64.56% |
| 2015 Q1 | 1.56 Million USD | 0.0% |
| 2015 FY | 4.24 Million USD | 170.62% |
| 2015 Q3 | 555.5 Thousand USD | 0.0% |
| 2014 Q4 | 1.56 Million USD | 0.0% |
| 2014 FY | 1.56 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -449.715% |
| Cerus Corporation | 143.15 Million USD | 56.9% |
| OrthoPediatrics Corp. | 137.01 Million USD | 54.97% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -443.092% |
| Talis Biomedical Corporation | 67.18 Million USD | 8.165% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -147.334% |
| Inogen, Inc. | 236.08 Million USD | 73.865% |
| Spectral AI, Inc. | 20.86 Million USD | -195.725% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -10.184% |
| CVRx, Inc. | 76.14 Million USD | 18.967% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1648.868% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -394.035% |
| Orthofix Medical Inc. | 667.42 Million USD | 90.756% |
| Venus Concept Inc. | 80.47 Million USD | 23.331% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -9.053% |
| Bioventus Inc. | 409.91 Million USD | 84.948% |
| BrainsWay Ltd. | 28.01 Million USD | -120.216% |
| Envoy Medical, Inc. | 17.89 Million USD | -244.731% |
| electroCore, Inc. | 32.03 Million USD | -92.626% |
| IceCure Medical Ltd | 16.87 Million USD | -265.608% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -45.409% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -249.912% |
| MaxCyte, Inc. | 84.84 Million USD | 27.279% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -397.109% |
| Nexalin Technology, Inc. | 5.78 Million USD | -967.224% |
| PAVmed Inc | 64.82 Million USD | 4.824% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -20.796% |
| RxSight, Inc. | 103.85 Million USD | 40.587% |
| Sight Sciences, Inc. | 126.44 Million USD | 51.206% |
| SI-BONE, Inc. | 156.35 Million USD | 60.538% |
| TELA Bio, Inc. | 84.18 Million USD | 26.711% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 11.928% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 69.66% |
| LivaNova PLC | 843.54 Million USD | 92.686% |
| 908 Devices Inc. | 68.08 Million USD | 9.371% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 87.241% |
| Nemaura Medical Inc. | 7.13 Million USD | -764.291% |
| NeuroPace, Inc. | 75.29 Million USD | 18.057% |
| LENSAR, Inc. | 33.33 Million USD | -85.085% |
| Apyx Medical Corporation | 51.01 Million USD | -20.938% |
| Cutera, Inc. | 197.72 Million USD | 68.795% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -148.981% |
| BioSig Technologies, Inc. | 28.53 Million USD | -116.264% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 67.776% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -71.104% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 92.623% |
| Axonics, Inc. | 270.2 Million USD | 77.165% |
| Outset Medical, Inc. | 198.77 Million USD | 68.959% |
| IRIDEX Corporation | 31.81 Million USD | -93.94% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 65.764% |
| IRadimed Corporation | 30.12 Million USD | -104.828% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -623.16% |
| INVO Bioscience, Inc. | 7.85 Million USD | -685.658% |
| Telesis Bio, Inc. | 63.48 Million USD | 2.818% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 37.331% |
| Varex Imaging Corporation | 224.8 Million USD | 72.553% |
| Quipt Home Medical Corp. | 148.66 Million USD | 58.498% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -426.316% |
| Pulmonx Corporation | 112.68 Million USD | 45.247% |
| Dynatronics Corporation | 9.9 Million USD | -522.727% |
| Modular Medical, Inc. | 17.52 Million USD | -251.988% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -205.642% |
| Semler Scientific, Inc. | 38.94 Million USD | -58.433% |
| InMode Ltd. | 215.68 Million USD | 71.393% |
| Bruker Corporation | 1.07 Billion USD | 94.268% |
| Cytosorbents Corporation | 48.33 Million USD | -27.646% |
| DexCom, Inc. | 1.69 Billion USD | 96.352% |
| Align Technology, Inc. | 2.07 Billion USD | 97.029% |
| Viveve Medical, Inc. | 22.17 Million USD | -178.266% |
| ZimVie Inc. | 275.12 Million USD | 77.574% |
| Movano Inc. | 29.69 Million USD | -107.814% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 55.052% |
| Nexalin Technology, Inc. | 5.78 Million USD | -967.224% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1648.868% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 89.732% |
| Profound Medical Corp. | 33.6 Million USD | -83.614% |
| Insulet Corporation | 939.9 Million USD | 93.435% |
| enVVeno Medical Corporation | 25.23 Million USD | -144.473% |
| Surmodics, Inc. | 98.69 Million USD | 37.485% |
| iCAD, Inc. | 22.22 Million USD | -177.615% |
| Nuwellis, Inc. | 22.61 Million USD | -172.852% |
| Biotricity, Inc. | 17.18 Million USD | -259.043% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 86.162% |
| Aethlon Medical, Inc. | 12.27 Million USD | -402.545% |
| InspireMD, Inc. | 22.95 Million USD | -168.845% |
| PAVmed Inc. | 64.82 Million USD | 4.824% |
| BIOLASE, Inc. | 34.66 Million USD | -78.01% |
| FONAR Corporation | 28.6 Million USD | -115.699% |
| AxoGen, Inc. | 149.33 Million USD | 58.684% |
| Vivani Medical, Inc. | 26.96 Million USD | -128.815% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 65.159% |
| Inari Medical, Inc. | 448.59 Million USD | 86.246% |
| UFP Technologies, Inc. | 58.08 Million USD | -6.216% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1152.131% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -876.53% |
| Tenon Medical, Inc. | 16.96 Million USD | -263.626% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -734.573% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -39.9% |
| AdaptHealth Corp. | 1.07 Billion USD | 94.276% |
| Sintx Technologies, Inc. | 15.2 Million USD | -305.894% |
| NanoVibronix, Inc. | 4.97 Million USD | -1140.7% |
| Quanterix Corporation | 118.1 Million USD | 47.756% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -426.316% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -327.226% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 84.287% |
| TransMedics Group, Inc. | 182.82 Million USD | 66.251% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -119.847% |
| NeuroMetrix, Inc. | 11.09 Million USD | -455.909% |
| Hyperfine, Inc. | 52.87 Million USD | -16.697% |
| Establishment Labs Holdings Inc. | 172 Million USD | 64.129% |
| Biomerica, Inc. | 6.97 Million USD | -784.208% |
| Bone Biologics Corporation | 9.42 Million USD | -554.413% |
| AVITA Medical, Inc. | 80.77 Million USD | 23.619% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -498.378% |
| Silk Road Medical, Inc | 186.35 Million USD | 66.892% |